Last reviewed · How we verify
YTTRIUM CHLORIDE
YTTRIUM CHLORIDE is a drug. It is currently FDA-approved (first approved 2003).
Yttrium Chloride is a small molecule used as a diagnostic agent. It has been studied in combination with other interventions, such as cisplatin, cytarabine, and etoposide, in clinical trials for various conditions including AIDS-related Lymphoma, Adult Non-Hodgkin's Lymphoma, and Hepatocellular Carcinoma.
At a glance
| Generic name | YTTRIUM CHLORIDE |
|---|---|
| Modality | Small molecule |
| Phase | FDA-approved |
| First approval | 2003 |
Approved indications
Common side effects
Key clinical trials
- Erbium, Chromium: Yttrium, Scandium, Gallium, Garnet (Er,Cr:YSGG) Laser in Root Canal Disinfection (NA)
- Using Radiotherapy and Immunotherapy to Treat Advanced Liver Cancer Before Transplant (PHASE1, PHASE2)
- Lasers as an Alternative to Formocresol and Sodium Hypochlorite Medicaments in Pulpotomy Techniques (PHASE4)
- Rituximab, Yttrium Y 90 Ibritumomab Tiuxetan in Patients W/Relapsed Stage II, III, or IV Follicular NHL (PHASE2)
- Efficacy Study of Intra-hepatic Administration of Therasphere® in Association With Intravenous Chemotherapy to Treat Cholangiocarcinoma (PHASE2)
- Combination Chemotherapy Followed by Rituximab and Yttrium Y 90 Ibritumomab Tiuxetan in Treating Patients With Relapsed or Refractory AIDS-Related Non-Hodgkin's Lymphoma (PHASE2)
- Hepatic Arterial Chemoembolization With Cisplatin or Internal Radiation Therapy in Treating Patients With Advanced Liver Cancer That Cannot Be Removed By Surgery (PHASE3)
- Radiolabeled Monoclonal Antibody, Combination Chemotherapy, and Peripheral Stem Cell Transplantation in Treating Patients With Recurrent or Refractory B-Cell Cancer (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| FDA label | Mechanism, indications, dosing, boxed warnings, drug interactions |
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- YTTRIUM CHLORIDE CI brief — competitive landscape report
- YTTRIUM CHLORIDE updates RSS · CI watch RSS
Frequently asked questions about YTTRIUM CHLORIDE
What is YTTRIUM CHLORIDE?
When was YTTRIUM CHLORIDE approved?
What development phase is YTTRIUM CHLORIDE in?
Related
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing